• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病诊断相关分组(DRG)改革政策对中国西部中风患者住院费用的影响:来自中医的智慧

Impact of DRG Reform Policies on Hospitalization Costs of Stroke Patients in Western China: Wisdom from Traditional Chinese Medicine.

作者信息

Wang Jiayi, Chen Mengen, Yang Jingyu

机构信息

School of Health Management, Gansu University of Chinese Medicine, Lanzhou, People's Republic of China.

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China.

出版信息

Risk Manag Healthc Policy. 2025 Jul 11;18:2401-2411. doi: 10.2147/RMHP.S525667. eCollection 2025.

DOI:10.2147/RMHP.S525667
PMID:40671692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12263817/
Abstract

BACKGROUND

Stroke presents a significant economic burden worldwide, with the impact being especially pronounced in developing countries. China is currently implementing Diagnosis-Related Group (DRG) reforms, attempting to use more traditional Chinese medicine (TCM) modalities to alleviate the economic burden on stroke patients.

METHODS

This retrospective study extracted the medical records of stroke inpatients at Qingyang City Hospital of TCM from 2017 to 2022 from China's Gansu National Health Big Data Platform. A single-group interrupted time series (ITS) design was employed to assess the impact of DRG reform on patients' hospitalization costs and length of stay (LOS). Additionally, a two-group ITS was utilized to evaluate treatment costs and medicine costs.

RESULTS

The single-group ITS analysis indicated that the average LOS decreased by 0.06 days per month following the reform (P < 0.05), while the average hospitalization cost declined by 48.92 yuan per month (P < 0.05). The two-group ITS results revealed a significant reduction in the average monthly cost of Western medicine by 22.67 yuan post-reform (P < 0.05), whereas the average monthly cost of Chinese medicine increased by 2.93 yuan, though this change was not statistically significant (P > 0.05). Additionally, the average monthly cost of Western medical treatment decreased by 11.24 yuan (P < 0.05). Acupuncture and massage treatment costs exhibited an initial sharp increase followed by a downward trend, with an average monthly decrease of 9.53 yuan (P < 0.05).

CONCLUSION

DRG reduced hospitalization costs and shortened the LOS of stroke patients, which may be related to the increased use of TCM in stroke treatment.

摘要

背景

中风在全球造成了巨大的经济负担,在发展中国家这种影响尤为显著。中国目前正在实施疾病诊断相关分组(DRG)改革,试图采用更多的中医治疗方式来减轻中风患者的经济负担。

方法

这项回顾性研究从中国甘肃国家卫生大数据平台提取了2017年至2022年庆阳市中医医院中风住院患者的病历。采用单组中断时间序列(ITS)设计来评估DRG改革对患者住院费用和住院时长(LOS)的影响。此外,采用两组ITS来评估治疗费用和药品费用。

结果

单组ITS分析表明,改革后平均住院时长每月减少0.06天(P < 0.05),而平均住院费用每月下降48.92元(P < 0.05)。两组ITS结果显示,改革后西药平均每月费用显著降低22.67元(P < 0.05),而中药平均每月费用增加2.93元,不过这一变化无统计学意义(P > 0.05)。此外,西医治疗平均每月费用下降11.24元(P < 0.05)。针灸和按摩治疗费用起初急剧上升,随后呈下降趋势,平均每月下降9.53元(P < 0.05)。

结论

DRG降低了中风患者的住院费用并缩短了住院时长,这可能与中风治疗中增加使用中医有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/bdcd2dffc50a/RMHP-18-2401-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/6cd2a073d9d3/RMHP-18-2401-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/638fcd52bb1e/RMHP-18-2401-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/27f24257d90e/RMHP-18-2401-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/bdcd2dffc50a/RMHP-18-2401-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/6cd2a073d9d3/RMHP-18-2401-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/638fcd52bb1e/RMHP-18-2401-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/27f24257d90e/RMHP-18-2401-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c38/12263817/bdcd2dffc50a/RMHP-18-2401-g0004.jpg

相似文献

1
Impact of DRG Reform Policies on Hospitalization Costs of Stroke Patients in Western China: Wisdom from Traditional Chinese Medicine.疾病诊断相关分组(DRG)改革政策对中国西部中风患者住院费用的影响:来自中医的智慧
Risk Manag Healthc Policy. 2025 Jul 11;18:2401-2411. doi: 10.2147/RMHP.S525667. eCollection 2025.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
9
Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.“口袋里的药丸”策略与偶发性院内治疗或持续性抗心律失常药物治疗相比,用于阵发性心房颤动的系统评价和成本效益评估。
Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310.
10
Elective THA for Indications Other Than Osteoarthritis Is Associated With Increased Cost and Resource Use: A Medicare Database Study of 135,194 Claims.择期全髋关节置换术用于治疗非骨关节炎的适应证与更高的成本和资源利用相关:一项基于 Medicare 数据库的 135194 例患者的研究。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1159-1170. doi: 10.1097/CORR.0000000000002922. Epub 2023 Nov 24.

本文引用的文献

1
Chinese herbal medicine and acupuncture for insomnia in stroke patients: A systematic review and meta-analysis of randomised controlled trials.中药和针灸治疗中风后失眠症的随机对照试验的系统评价和荟萃分析。
Sleep Med. 2024 Aug;120:65-84. doi: 10.1016/j.sleep.2024.05.006. Epub 2024 May 11.
2
Impacts of the Zero-Markup Drug Policy on Hospitalization Expenses of Patients with Stroke in Western China: An Interrupted Time Series Analysis.零差价药品政策对中国西部脑卒中患者住院费用的影响:一项中断时间序列分析
Risk Manag Healthc Policy. 2024 Apr 3;17:777-788. doi: 10.2147/RMHP.S456977. eCollection 2024.
3
Substance basis and pharmacological mechanism of heat-clearing herbs in the treatment of ischaemic encephalopathy: a systematic review and network pharmacology.
清热药治疗缺血性脑病的物质基础及药理学机制:系统评价与网络药理学。
Ann Med. 2024 Dec;56(1):2308077. doi: 10.1080/07853890.2024.2308077. Epub 2024 Jan 29.
4
Pharmacodynamic advantages and characteristics of traditional Chinese medicine in prevention and treatment of ischemic stroke.中药在缺血性脑卒中防治中的药效学优势与特点
Chin Herb Med. 2023 Oct 9;15(4):496-508. doi: 10.1016/j.chmed.2023.09.003. eCollection 2023 Oct.
5
Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms.中药治疗缺血性中风及其主要生物活性成分和作用机制。
Phytother Res. 2024 Jan;38(1):411-453. doi: 10.1002/ptr.8033. Epub 2023 Dec 5.
6
A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine.中西医中与中风相关的信号通路及治疗的综合综述。
Front Neurosci. 2023 Jun 7;17:1200061. doi: 10.3389/fnins.2023.1200061. eCollection 2023.
7
The role of traditional herbal medicine for ischemic stroke: from bench to clinic-A critical review.传统草药在缺血性中风中的作用:从实验室到临床——批判性评价。
Phytomedicine. 2023 Jan;109:154609. doi: 10.1016/j.phymed.2022.154609. Epub 2022 Dec 17.
8
The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study.零加成药品政策对患者医疗服务利用及费用的影响:一项中断时间序列研究。
Front Med (Lausanne). 2022 Nov 15;9:928690. doi: 10.3389/fmed.2022.928690. eCollection 2022.
9
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022.世界卒中组织(WSO):全球卒中状况 2022 概要。
Int J Stroke. 2022 Jan;17(1):18-29. doi: 10.1177/17474930211065917.
10
Challenges and Improvements of Novel Therapies for Ischemic Stroke.缺血性中风新型疗法的挑战与改进
Front Pharmacol. 2021 Sep 30;12:721156. doi: 10.3389/fphar.2021.721156. eCollection 2021.